免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA PMA

用于脑动静脉畸形栓塞的组织粘合剂

PMA编号:P990040 · 2026-05-26

决定日期2026-05-26
PMA 编号P990040
产品代码KGG
设备分类第3类
医疗专科U
咨询委员会NE 请注意,您提供的文本“NE”不足以进行翻译,因为它不是一个完整的句子或描述。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。

器械摘要

tissue adhesive for use in embolization of brain arteriovenous malformations is the device name listed in this FDA 510(k) record. The listed applicant is Cerenovus, Inc.. It received FDA 510(k) clearance on 2026-05-26. The device is classified under product code KGG. It was reviewed by the NE advisory panel.

常见问题

What is the tissue adhesive for use in embolization of brain arteriovenous malformations?

tissue adhesive for use in embolization of brain arteriovenous malformations is a medical device that received FDA 510(k) clearance on 2026-05-26. The listed applicant is Cerenovus, Inc..

When did tissue adhesive for use in embolization of brain arteriovenous malformations receive FDA 510(k) clearance?

The clearance date for tissue adhesive for use in embolization of brain arteriovenous malformations can be found in the official FDA records.

Who is the listed applicant for tissue adhesive for use in embolization of brain arteriovenous malformations?

FDA 510(k)记录中列出Cerenovus, Inc.为申请人。这本身并不能确立该设备制造商的身份。

What is the FDA product code for tissue adhesive for use in embolization of brain arteriovenous malformations?

The FDA product code for tissue adhesive for use in embolization of brain arteriovenous malformations is KGG.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑